Clinical Trials Directory

Trials / Unknown

UnknownNCT05842993

Study of Hydrogen Inhalation Compared With Placebo in Type 2 Diabetes Patients

Efficacy and Safety of Hydrogen Inhalation in Subjects With Type 2 Diabetes

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
96 (estimated)
Sponsor
Qingdao University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of hydrogen inhalation in type 2 diabetes patients.

Detailed description

The objective of the study is to evaluate the efficacy and safety of hydrogen inhalation compared with placebo in patients with type 2 diabetes mellitus after 12-week treatment in a randomized, double-blind, placebo-controlled design.

Conditions

Interventions

TypeNameDescription
DEVICEHydrogen generatorPatient inhales hydrogen gas for 2 hours per day in the flow rate of 2L/min via nasal cannula by applying hydrogen generator (HZS-2700A, Qingdao Haizhisheng Corp.,LTD, Qingdao, China) for 12 weeks.
DEVICEAnalogue machinePatient inhales normal air for 2 hours per day in the flow rate of 2L/min via nasal cannula with analogue machine for 12 weeks. This machine has the same appearance as the hydrogen generator.

Timeline

Start date
2023-05-01
Primary completion
2023-10-10
Completion
2023-10-10
First posted
2023-05-06
Last updated
2023-05-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05842993. Inclusion in this directory is not an endorsement.